PDR for Herbal Medicines

506 /MARSHMALLOW PDR FOR HERBAL MEDICINES

Daily Dosage: The average daily dose is 6 gm of the root

and 5 gm of the leaf. The tea dosage is several cups of the

slightly warmed tea taken during the course of the day. A

single dose of the syrup is 10 gm.

Storage: The drug should be protected from light sources

and insects.

LITERATURE

Blaschek W, Franz G, (1986) Planta Med 6:76P.

Capek P, et al., Carbohydr Res 164:443. 1987.

Franz G, Madaus A, Stabilitat von Polysacchariden.

Untersuchungen am Beispiel des Eibischschleims. In: DAZ

130(40):2194. 1990.

Franz G, PM 14:90. 1966.

Franz G, PM 55:493. 1989.

Gudej J, (1981) Acta Pol Pharm 38:385.

Gudej J, Bieganowska HL, Chromatographia 30:333. 1990.

Gudej J, PM 57:284. 1991.

Hahn-Deinstrop E, Eibischwurzel Identifizierung von

Eibischwurzel-Extrakt und Gehaltsbestimmung in einem Instant-

Tee. In: DAZ 135(13): 1147-1149. 1995.

Kardosova A, et al., (1983) Coll Czech Commun 45:2082.

Kochich P, et al., (1983) Sov J Bioorg Chem 9(2): 121.

Nosal'ova G, Strapkova A, Kardosova A, Capek P, Zatureck'y

L, Bukovska E, Antitussive Wirkung des Extraktes und der

Polysaccharide aus Eibisch (Althaea officinalis L. var. robusta).

In: PA 47(3):224-226. 1992.

Nosolova G, et al., PA 47:224. 1993.

Shimizu N, Tomoda T, Chem Pharm Bull 33:5539. 1985.

Tomoda M et al., (1977) Chem Pharm Bull 25:1357.

Tomoda1vf^ral^(l9.80X.Chem Pharm Bull 28:824^

Tomoda M et al., (1987) Planta Med 53(1):8.

Wunderer H, Zentral und peripher wirksame Antitussiva: eine

kritische Ubersicht. In: PZ 142(11):847-852. 1997.

Further information in:

Hansel R, Keller K, Rimpler H, Schneider G (Hrsg.), Hagers

Handbuch der Pharmazeutischen Praxis, 5. AufL, Bde 4-6

(Drogen), Springer Verlag Berlin, Heidelberg, New York, 1992-

1994.

Madaus G, Lehrbuch der Biologischen Arzneimittel, Bde 1-3,

Nachdruck, Georg Olms Verlag Hildesheim 1979.

Schulz R, Hansel R, Rationale Phytotherapie, Springer Verlag

Heidelberg 1996.

Steinegger E, Hansel R, Pharmakognosie, 5. AufL, Springer

Verlag Heidelberg 1992.

Teuscher E, Biogene Arzneimittel, 5. AufL, Wiss. Verlagsges.
Stuttgart 1997.

Wagner H, Wiesenauer M, Phytotherapie. Phytopharmaka und

pflanzliche Homoopathika, Fischer-Verlag, Stuttgart, Jena, New

York 1995.

Wichtl M (Hrsg.), Teedrogen, 4. AufL, Wiss. Verlagsges.

Stuttgart 1997.

Martagon

Lilium martagon

DESCRIPTION

Medicinal Parts: The medicinal parts are the leaves, stem

and flowers, which are collected when the plant is complete-

ly mature.

Flower and Fruit: The inflorescence is terminal and

racemous with 3 to 10 inclined flowers. The flower buds are

globose or oblong-ovate. The tepal petals are 3 to 3.5 cm

long, involute and orange with dark spots. They contain a

ciliate mauve honey gland. The anthers are red. The fruit is a

2-winged capsule witJi an erect fruit stem. The seeds are flat,

light brown and 6 to 8 mm long. Since the seeds do not ripen

in northern regions, propagation takes place by means of

bulbils, which occur at the leaf axils. Flowers are produced

during the third year of growth.

Leaves, Stem and Root: The plant is a perennial, 30 to 60 cm

high or higher. The bulb is golden yellow, ovate and about 5

cm long. The stem is erect, round, glabrous or with short

rough hairs on the upper section. The stem is green or

spotted red and leafy in the middle. The leaves are 7 to 11

ribbed, oblong-spatulate, shortly ciliated and up to 15 cm

long.

Habitat: The plant comes from China and Japan, but is also

cultivated in central and southern Europe.

Production: Martagon is the tuber of Lilium martagon.

Other Names: Purple Turk's Cap Lily, Turk's Cap

ACTIONS AND PHARMACOLOGY

COMPOUNDS

Soluble polysaccharides

Starch

Gamma-methylene glutamic acid

Tuliposide

The constituents of the drug have not been fully investigated.

EFFECTS

No information is available.